NEWS
Advanced Radiopharmacy Training Delivered by Medicheck for PT Kalbe Farma Tbk’s Surabaya Team
We recently hosted another group from PT Kalbe Farma Tbk’s radiopharmaceutical production facility in Surabaya, Indonesia, at Medicheck’s facilities in Istanbul.
More
Radiopharmacy Immersion Training for a Public Hospital in Indonesia
We hosted the team from RS UPT Vertikal Makassar, a government hospital under the Indonesian Ministry of Health, at Medicheck’s facilities in Istanbul.
More
Medicheck Completes Regulatory Submission for Flotufolastat F-18 (POSLUMA®) – Türkiye’s First F-18 PSMA PET Imaging Agent.
Medicheck has submitted a Marketing Authorization Application (MAA) to the Turkish Medicines and Medical Devices Agency (TMMDA) for flotufolastat F-18 (commercial name POSLUMA®), under its technology transfer and licensing agreement with Blue Earth Diagnostics.
More
IMS Team Completes Radiopharmacy Training at Medicheck in Preparation for Batang Cyclotron Facility.
It was a pleasure to welcome the Interskala Medika Solusindo (IMS) team to Medicheck in Istanbul.
More
Kalbe Farma team successfully completed the comprehensive Radiopharmacy training provided by Medicheck.
GE HealthCare's guests from PT Kalbe Farma Tbk team who will soon be operating Kalbe's first radiopharmaceutical facility in Jakarta received a comprehensive Radiopharmacy training at the Medicheck premises in Istanbul.
More
Certificates were given to the participants in the "Radiopharmacy Immersion" training provided by Medicheck.
GE HealthCare guests from Iraq successfully completed the "Radiopharmacy Immersion" training held at Medicheck facility in İstanbul between 13-17 November 2023 and received their certificates. Medicheck wishes success to the participants in their radiopharmacy operations.
More
We participated the 15th National Parkinson's Disease and Movement Disorders Congress with GE HealthCare.
Together with GE HealthCare, we participated in the 15th National Parkinson's Disease and Movement Disorders Congress held in Hilton Dalaman Sarıgerme between 15-19 March 2023 as a sponsor. We had the chance to exchange ideas and make mutual discussions in productive meetings with our esteemed physicians, one of the important stakeholders of the sector, and members of the Turkish Parkinson's Disease Association, representing patients’ relatives..
More
We participated the 35th National Nuclear Medicine Congress.
We attended the 35th National Nuclear Medicine Congress held in Titanic Congress Center - Belek, Antalya between 26-30 April 2023 and had the opportunity to meet our esteemed physicians and industry partners.
More
Medicheck Hosted GE Healthcare's Training
Medicheck Silivri facility hosted the "PETtrace 800 series Service Training L1" training organized by GE Healthcare between 08-19 December 2022, with the participation of Medicheck engineers as well as international participants.
MoreMedicheck attended the 34th National Nuclear Medicine Congress
Participated in the 34th National Nuclear Medicine Congress held at Antalya Kaya Palazzo Congress Center as a silver sponsor.
MoreDaTSCAN and Vizamyl products were launched in Turkey at the 55th National Neurology Congress
At the 55th National Neurology Congress with the Main Theme of “Movement Disorders”, with The Satellite Symposium titled "Parkinson or Alzheimer's? A New Dimension in Neuroimaging", which Chaired by Prof. Dr. Murat Emre and Prof.Dr. Jakub Hort, Prof.Dr. Paolo Barone were speakers, was held under the sponsorship of GE Healthcare and Medicheck, the Turkish launch of DaTSCAN and Vizamyl products was held at Antalya Maritim Pine Beach Hotel with high participation and interest.
More
Amyloid PET imaging agent VIZAMYL is in Turkey with domestic production
Granted to high priority licensing process by TITCK, with the completion of the licensing process of our product, Vizamyl® (18F-Flutemetamol), Turkey has become one of the few countries where Amyloid PET can be scanned.
More